Caricamento...
Cancer chemoprevention research with selenium in the post-SELECT era: Promises and challenges
The negative efficacy outcomes of double-blinded, randomized, placebo-controlled Phase III human clinical trials with selenomethionine (SeMet) and SeMet-rich selenized-yeast (Se-yeast) for prostate cancer prevention and Se-yeast for prevention of non-small cell lung cancer (NSCLC) in North America l...
Salvato in:
| Pubblicato in: | Nutr Cancer |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4822195/ https://ncbi.nlm.nih.gov/pubmed/26595411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/01635581.2016.1105267 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|